Introduction {#s1}
============

The pathophysiology of lower urinary tract dysfunction (LUTD) can involve either bladder or urethral problems, and distinguishing these subgroups of female LUTD is essential for providing proper treatment. Unfortunately, some kinds of LUTD can produce similar clinical symptoms. For example, overactive bladder syndrome and polyuria can have increased urinary frequency as a symptom. Symptom-based treatment can be ineffective and lead to drug-related adverse side effects, such as dry mouth, pruritus, and constipation [@pone.0069946-Chapple1]. Accurate assessment of patient bladder capacity may be important in determining the proper initial treatment for LUTD and as well as for monitoring therapeutic outcomes [@pone.0069946-Warner1], [@pone.0069946-deBadiola1]. Bladder capacity can be determined from a bladder diary, by uroflowmetry, or by filling cystometry [@pone.0069946-Ertberg1].

Cystometric maximum bladder capacity is a frequently used metric for evaluating therapeutic effects [@pone.0069946-Lowenstein1]--[@pone.0069946-Hsiao1]. However, most people go to the toilet when they have a strong desire to void and do not wait until a sensation of urgency. In addition, we have reported that in women with stress incontinence, infusion of a strong-desire-water-volume in a 20-minute pad test produced better sensitivity than that of infusion of 250 ml water [@pone.0069946-Wu1], [@pone.0069946-Wu2]. Thus, the volume at strong desire to void (VSD) determined from filling cystometry is an important clinical parameter. However, many primary care physicians do not have the equipment for performing uroflowmetry or urodynamic studies. Therefore, the aim of this study was to identify the bladder diary parameters that are best correlated to VSD.

Materials and Methods {#s2}
=====================

This study was approved by the National Taiwan University Hospital Research Ethics Committee. Informed consents of our participants were not obtained due to that the data were analyzed anonymously and this is a retrospective study, and the National Taiwan University Hospital Research Ethics Committee waived the need for written informed consent form the participants. In general, we excluded women of less than 18 year-old, active urinary tract infections, proven bladder cancer or stones, or neurogenic lesions (such as spinal cord injury or stroke) to undergo urodynamic studies in our department. Women who underwent urodynamic studies between January 2009 and December 2011 at a university hospital were retrospectively included in this study. We reviewed their medical records, including clinical data, results of urodynamic studies, and 3-day bladder diaries. If the patients had received treatment for their lower urinary tract symptoms, post-treatment urodynamic studies and bladder diaries were also reviewed.

Bladder diary data included voided volume, time of voiding, and time to sleep. Maximum voided volume was referred to be the largest voided volume during 24 hour (i.e., including daytime and nighttime) bladder diary. It has been previously reported that the largest voided volumes during the day tend to occur in the morning because there is a decreased awareness of bladder filling during sleep. Therefore, the bladder capacity in the morning differs from the "normal" bladder capacity [@pone.0069946-Ertberg1], [@pone.0069946-Parsons1]. Because of this, we excluded the first morning voided volume in determining the maximum daytime voided volume, and DVVmax is referred to be the largest voided volume during the daytime voided volumes excluding the first morning void. DVVmaxavg means the average voided volume of day 1, 2, and 3 DVVmax. In addition, VVmax is referred to be the largest voided volume during the 24-hour voided volumes, and VVmaxavg means the average voided volume of day 1, 2, and 3 VVmax in this study.

We performed urodynamic studies with the women in a seated position using a Life-Tech six-channel monitor with computer analysis and the Urolab/Urovision System V (Houston, Texas, USA). These studies included uroflowmetry, filling cystometry (at a rate of 60 ml/min), voiding cystometry (with an infusion of 35°C distilled water), and stress urethral pressure profiles (with a strong-desire volume of distilled water in the bladder). All terminology used in this paper conforms to the standards recommended by the International Urogynecological Association and International Continence Society joint report [@pone.0069946-Haylen1]. All procedures were performed by an experienced technician, and the data were interpreted by a single observer to avoid inter-observer variability. Bladder oversensitivity was defined as an early strong desire to void, corresponding to VSD \<250 ml during filling cystometry [@pone.0069946-Haylen1], [@pone.0069946-Abrams1].

STATA software (Version 11.0; Stata Corporation, College Station, Texas, USA) was used for statistical analysis. Wilcoxon signed-rank test and Spearman rank-correlation coefficient were used, where appropriate. A p value \<0.05 was considered statistically significant. ROC curve analysis was performed to identify the optimal maximum voided volume of bladder diaries for detecting bladder oversensitivity.

Results {#s3}
=======

We reviewed urodynamic and bladder diary data from a total of 900 women, and clinical diagnoses or indications included overactive bladder syndrome (n = 381), overactive bladder syndrome and stress urinary incontinence (n = 297), stress urinary incontinence (n = 175), voiding dysfunction (n = 35) and miscellaneous indications (such as evaluation for occult incontinence in women with pelvic organ prolapse, n = 12, [Table 1](#pone-0069946-t001){ref-type="table"}).

10.1371/journal.pone.0069946.t001

###### Comparisons of baseline, cystometric and bladder dairy parameters for women underwent urodynamic studies (n = 900).

![](pone.0069946.t001){#pone-0069946-t001-1}

  Diagnoses or indications                  OAB       OAB+SUI       SUI         VD       Miscellaneous   *P* [†](#nt101){ref-type="table-fn"}
  ------------------------------------- ----------- ----------- ----------- ----------- --------------- --------------------------------------
  Number of patients                        381         297         175         35            12                          --
  Age (years)                            56.9±13.4   58.5±11.6   58.3±12.5   57.5±14.5     56.6±13.7                     0.55
  Parity                                  3.0±1.4     3.1±1.6     3.2±1.6     3.1±1.1       3.1±1.6                      0.74
  FD (ml)                                 135±49      146±50      162±45      156±54        171±39                     \<0.001
  ND (ml)                                 179±61      192±64      219±63      206±71        233±48                     \<0.001
  VSD (ml)                                238±86      263±98      299±99      277±95        321±88                     \<0.001
  Urgency (ml)                            304±103     320±107     396±114     350±108       406±96                     \<0.001
  Day 1 VVmax (ml)                        300±132     326±153     387±167     309±129       320±144                    \<0.001
  Day 2 VVmax (ml)                        306±134     328±151     405±178     299±107       299±128                    \<0.001
  Day 3 VVmax (ml)                        307±142     329±156     403±186     328±148       357±149                    \<0.001
  The maximum of days1--3 VVmax (ml)      356±153     388±168     472±193     388±129       383±151                    \<0.001
  VVmaxavg (ml)                           304±122     328±135     398±156     312±105       325±129                    \<0.001
  Day 1 DVVmax (ml)                       244±107     268±127     317±136     271±109       272±148                    \<0.001
  Day 2 DVVmax (ml)                       244±107     252±119     312±136     270±93        254±126                    \<0.001
  Day 3 DVVmax (ml)                       236±109     257±124     311±147     294±142       289±140                    \<0.001
  The maximum of days1--3 DVVmax (ml)     287±118     312±140     381±152     356±126       324±157                    \<0.001
  DVVmaxavg (ml)                          242±95      259±107     313±119     278±89        271±126                    \<0.001

ANOVA with Bonferroni correction: all cystometric and bladder diary parameters - OAB vs. SUI, *P*\<0.001; OAB +SUI vs. SUI, *P*\<0.001; the other diagnosis/indications subgroup pairs are not uniformly significant.

Values are given as mean ± standard deviation. DVVmax = maximum daytime voided volume excluding the morning void; DVVmaxavg = the average of day 1 to day 3 DVVmax; FD = the volume at first desire to void; ND = the volume at normal desire to void; OAB = overactive bladder syndrome; SUI = stress urinary incontinence; VD = voiding dysfunction; VSD = the volume at strong desire to void; VVmax = maximum voided volume; VVmaxavg = the average of day 1 to day 3 VVmax.

Baseline clinical, urodynamic, and bladder diary variables are tabulated in [Table 2](#pone-0069946-t002){ref-type="table"}. DVVmaxavg had the similar mean values and highest correlation with VSD at ρ = 0.51 (263 vs. 261 mL); and VVmaxavg had the similar mean values and high correlation with the volume at urgency (331 vs. 330 mL, ρ = 0.50). From the linear regression analysis, we found that the predictive value of VSD was 146+0.44 × DVVmaxavg (P\<0.001, [Figure 1](#pone-0069946-g001){ref-type="fig"}), and the predictive value of the volume at urgency was 194+0.41 × VVmaxavg (P\<0.001, [Figure 2](#pone-0069946-g002){ref-type="fig"}). DVVmax for days 1, 2, and 3 were all significantly associated with VSD with similar mean volumes. The predictive value of VSD was 179+0.31 × day 1 DVVmax (P\<0.001, [Figure 3](#pone-0069946-g003){ref-type="fig"}), and the predictive value of the volume at urgency was 221+0.34 × day 1 VVmax (P\<0.001, [Figure 4](#pone-0069946-g004){ref-type="fig"}).

![Regression fit scatter plot of the average of day 1 to day 3 daytime maximum voided volumes excluding the first morning void (DVVmaxavg) vs. the volume at strong desire to void (VSD).](pone.0069946.g001){#pone-0069946-g001}

![Regression fit scatter plot of day 1 daytime maximum voided volume excluding the first morning void (day 1 DVVmax) vs. VSD.](pone.0069946.g002){#pone-0069946-g002}

![Regression fit scatter plot of the average of day 1 to day 3 maximum voided volumes (VVmaxavg) vs. the volume at urgency.](pone.0069946.g003){#pone-0069946-g003}

![Regression fit scatter plot of day 1 maximum voided volume (VVmax) vs. the volume at urgency.](pone.0069946.g004){#pone-0069946-g004}
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###### Baseline clinical, urodynamic, and bladder diary variables and correlations between the volume at strong desire to void (VSD) and bladder diary variables in 900 women with lower urinary tract symptoms.

![](pone.0069946.t002){#pone-0069946-t002-2}

  Variables                                Values     ρ[†](#nt103){ref-type="table-fn"} for FD   ρ[†](#nt103){ref-type="table-fn"} for ND   ρ[†](#nt103){ref-type="table-fn"} for VSD   ρ[†](#nt103){ref-type="table-fn"} for Urgency
  -------------------------------------- ----------- ------------------------------------------ ------------------------------------------ ------------------------------------------- -----------------------------------------------
  Age (years)                             57.7±12.7                      --                                         --                                         --                                            --
  Parity                                   3.1±1.5                       --                                         --                                         --                                            --
  FD (ml)                                  145±49                        --                                         --                                         --                                            --
  ND (ml)                                  193±64                        --                                         --                                         --                                            --
  VSD (ml)                                 261±96                        --                                         --                                         --                                            --
  Urgency (ml)                             330±112                       --                                         --                                         --                                            --
  Day 1 VVmax (ml)                         326±150                      0.37                                       0.40                                       0.42                                          0.45
  Day 2 VVmax (ml)                         332±152                      0.39                                       0.41                                       0.43                                          0.45
  Day 3 VVmax (ml)                         334±160                      0.42                                       0.43                                       0.47                                          0.48
  The maximum of days 1--3 VVmax (ml)      391±170                      0.41                                       0.43                                       0.47                                          0.48
  VVmaxavg (ml)                            331±137                      0.43                                       0.45                                       0.49                                          0.50
  Day 1 DVVmax (ml)                        268±122                      0.38                                       0.42                                       0.43                                          0.45
  Day 2 DVVmax (ml)                        261±119                      0.41                                       0.43                                       0.46                                          0.48
  Day 3 DVVmax (ml)                        260±126                      0.43                                       0.44                                       0.46                                          0.45
  The maximum of days 1--3 DVVmax (ml)     317±137                      0.41                                       0.44                                       0.47                                          0.49
  DVVmaxavg (ml)                           263±107                      0.46                                       0.48                                       0.51                                          0.52

Each cystometric and bladder dairy parameters are compared with Spearman rank-correlation coefficient, and all *P*\<0.001.

Values are given as mean ± standard deviation or correlation coefficient.

Abbreviations same as [Table 1](#pone-0069946-t001){ref-type="table"}.

There were 158 patients that received follow-up assessments for monitoring therapeutic effects. The baseline and follow-up data for this group are shown in [Table 3](#pone-0069946-t003){ref-type="table"}. Duration from baseline to follow-up was ≥12 weeks for all patients. Among this group, 75% (118/158) were diagnosed as having overactive bladder syndrome. The changes from baseline in DVVmaxavg were significantly correlated to that of VSD (ρ = 0.32, [Figure 5](#pone-0069946-g005){ref-type="fig"}). The changes from baseline in DVVmax for days 1 through 3 were also significantly correlated with that of VSD and had similar mean volumes (ρ = 0.22, 0.25, and 0.25, respectively). However, these significant correlations did not exist among the corresponding parameters of the 24-h (i.e., daytime and nighttime) bladder diary. In addition, the change from baseline in VVmaxavg was significantly correlated to that of urgency (mean 12 vs. 32 mL, ρ = 0.17, P = 0.04, [Table 3](#pone-0069946-t003){ref-type="table"}, [Figure 6](#pone-0069946-g006){ref-type="fig"}).

![Regression fit scatter plot of the change from baseline in DVVmaxavg vs. the change from baseline in VSD.](pone.0069946.g005){#pone-0069946-g005}

![Regression fit scatter plot of the change from baseline in VVmaxavg vs. the change from baseline in urgency.](pone.0069946.g006){#pone-0069946-g006}

10.1371/journal.pone.0069946.t003

###### Baseline and follow-up data from urodynamic studies and bladder diaries and the correlations between the changes in VSD, urgency and the bladder diary parameters in 158 women.

![](pone.0069946.t003){#pone-0069946-t003-3}

                                         Therapeutic effect   Correlation with change of VSD   Correlation with change of Urgency                                    
  ------------------------------------- -------------------- -------------------------------- ------------------------------------ --------- ------ --------- ------ ---------
  Age (years)                                60.1±39.1                      --                                 --                     --       --      --       --      --
  Parity                                      2.9±1.4                       --                                 --                     --       --      --       --      --
  VSD (ml)                                     245±78                     270±81                             25±69                  \<0.001    --      --       --      --
  Urgency (ml)                                 319±91                    351±110                             32±82                  \<0.001    --      --       --      --
  Day 1 VVmax (ml)                            325±132                    345±138                             19±135                  0.15     0.11    0.15     0.18    0.02
  Day 2 VVmax (ml)                            336±140                    346±141                             9±142                   0.77     0.09    0.26     0.14    0.08
  Day 3 VVmax (ml)                            345±152                    349±132                             4±160                   0.40     0.09    0.28     0.07    0.40
  The maximum of days1--3 VVmax (ml)          398±155                    406±150                             8±149                   0.59     0.13    0.11     0.15    0.06
  VVmaxavg (ml)                               335±124                    347±123                             12±111                  0.38     0.12    0.14     0.17    0.04
  Day 1 DVVmax (ml)                           267±121                    287±112                             20±130                  0.005    0.22    0.005    0.30   \<0.001
  Day 2 DVVmax (ml)                           259±116                    286±104                             26±121                  0.007    0.24    0.002    0.25    0.001
  Day 3 DVVmax (ml)                           248±123                    275±114                             29±130                  0.002    0.25    0.002    0.20    0.01
  The maximum of days1--3 DVVmax (ml)         315±137                    340±115                             26±141                  0.001    0.25    0.002    0.25    0.002
  DVVmaxavg (ml)                              258±102                     283±93                             22±99                  \<0.001   0.32   \<0.001   0.32   \<0.001

Wilcoxon signed-rank test.

The changes of voided volumes of bladder diaries were compared with the changes of the volume at strong desire to void or urgency by Spearman rank-correlation coefficient.

Abbreviations same as [Table 1](#pone-0069946-t001){ref-type="table"}.

DVVmaxavg had the highest receiver operating characteristic curve (ROC) area for predicting bladder oversensitivity (0.75, 95% confidence interval = 0.72--0.78, [Figure 7](#pone-0069946-g007){ref-type="fig"}). The DVVmaxavg cutoff point of 250 ml (sensitivity 70.9%, specificity 65.8%) had a good predictive value for detecting bladder oversensitivity. The ROC area of day 1 DVVmax was 0.71 (95% confidence interval = 0.68--0.75, [Figure 8](#pone-0069946-g008){ref-type="fig"}). The day 1 DVVmax cutoff point of 250 ml (sensitivity 70.6%, specificity 59.1%) also had a good predictive value for detecting bladder oversensitivity.

![Receiver operating characteristic (ROC) curve for diagnosing bladder oversensitivity for the average of the daytime maximum voided volume excluding the first morning void.](pone.0069946.g007){#pone-0069946-g007}

![Receiver operating characteristic (ROC) curve for diagnosing bladder oversensitivity for day 1 daytime maximum voided volume excluding the first morning void.](pone.0069946.g008){#pone-0069946-g008}

The correlation coefficients of the VVmax and DVVmax between day 1, day 2, day 3 and their averages were good with a range of 0.70 to 0.91 (all P\<0.001, [Table 4](#pone-0069946-t004){ref-type="table"} and [5](#pone-0069946-t005){ref-type="table"}).

10.1371/journal.pone.0069946.t004

###### Correlation matrix of day 1, day 2, day 3 VVmax and their averages (n = 900).

![](pone.0069946.t004){#pone-0069946-t004-4}

                                Day 1 VVmax (ml)                       Day 2 VVmax (ml)                       Day 3 VVmax (ml)
  ------------------ -------------------------------------- -------------------------------------- --------------------------------------
  Day 2 VVmax (ml)    0.72[†](#nt109){ref-type="table-fn"}                    --                                     --
  Day 3 VVmax (ml)    0.70[†](#nt109){ref-type="table-fn"}   0.75[†](#nt109){ref-type="table-fn"}                    --
  VVmaxavg (ml)       0.88[†](#nt109){ref-type="table-fn"}   0.91[†](#nt109){ref-type="table-fn"}   0.91[†](#nt109){ref-type="table-fn"}

Spearman rank-correlation coefficient (ρ), and all *P* are \<0.001.

Abbreviations same as [Table 1](#pone-0069946-t001){ref-type="table"}.

10.1371/journal.pone.0069946.t005

###### Correlation matrix of day 1, day 2, day 3 DVVmax and their averages (n = 900).

![](pone.0069946.t005){#pone-0069946-t005-5}

                                Day 1 DVVmax (ml)                      Day 2 DVVmax (ml)                      Day 3 DVVmax (ml)
  ------------------- -------------------------------------- -------------------------------------- --------------------------------------
  Day 2 DVVmax (ml)    0.70[†](#nt111){ref-type="table-fn"}                    --                                     --
  Day 3 DVVmax (ml)    0.65[†](#nt111){ref-type="table-fn"}   0.71[†](#nt111){ref-type="table-fn"}                    --
  DVVmaxavg (ml)       0.88[†](#nt111){ref-type="table-fn"}   0.89[†](#nt111){ref-type="table-fn"}   0.88[†](#nt111){ref-type="table-fn"}

Spearman rank-correlation coefficient (ρ), and all *P* are \<0.001.

Abbreviations same as [Table 1](#pone-0069946-t001){ref-type="table"}.

Discussion {#s4}
==========

Yoon and Swift reported a good correlation between maximum bladder capacities determined from bladder diary and filling cystometry (ρ = 0.47, *P*\<0.001) [@pone.0069946-Yoon1]. However, in a similar study, Ertberg et al. reported the same correlation to be poor [@pone.0069946-Ertberg1]. In our study, we found that the maximum daytime void volume excluding first morning void was well-correlated with VSD determined by filling cystometry (ρ = 0.43 to 0.51, all *P*\<0.001), similar to Yoon and Swift [@pone.0069946-Yoon1]. Ertberg et al. and Yoon and Swift both reported that the bladder diary capacity was significantly higher than cystometry capacity (400 ml vs. 215 ml \[median\], *P* = 0.017 [@pone.0069946-Ertberg1]; and 401 ml vs. 342 ml \[mean\] [@pone.0069946-Yoon1]). McCormack et al. reported that bladder capacity from cystoscopy was higher than that from bladder diary by 206 ml [@pone.0069946-McCormack1]. The significant differences between these different methods limit the ability to compare the bladder diary capacity data with the bladder capacity data determined by other methods. However, DVVmaxavg showed a similar mean volume and a linear correlation with VSD ([Table 2](#pone-0069946-t002){ref-type="table"}, [Figure 1](#pone-0069946-g001){ref-type="fig"}), and therefore we can extrapolate VSD from the DVVmaxavg obtained from bladder diaries.

There have been a number of pharmacological studies using cystometry parameters to assess bladder capacity [@pone.0069946-Lowenstein1]--[@pone.0069946-Hsiao1]. To our knowledge, there is a lack of evidence to suggest that a change from baseline in cystometric bladder capacity can be used to extrapolate bladder capacity determined from bladder diary [@pone.0069946-Ertberg1]. In our study, the change from baseline in DVVmaxavg had a similar mean and was well-correlated with that of VSD ([Table 3](#pone-0069946-t003){ref-type="table"}, [Figure 5](#pone-0069946-g005){ref-type="fig"}). Although the change from baseline in VVmaxavg was significantly correlated to that of urgency; however, the mean changes from baseline in DVVmaxavg and VSD were more similar (mean 22 vs. 25 mL, respectively), and their correlation efficient was higher (ρ = 0.32) than those of VVmaxavg and urgency (mean 12 vs. 32 mL, respectively; ρ = 0.17, [Table 3](#pone-0069946-t003){ref-type="table"}). Thus, DVVmaxavg may be a better alternative parameter than VVmaxavg to evaluate the therapeutic outcomes of bladder storage disorders.

Mazurick et al. found no clinical benefit to extending a 1-day diary to 3 days [@pone.0069946-Mazurick1]. van Melick et al. also reported that adding additional days to a 1-day diary did not add significant information [@pone.0069946-vanMelick1]. Fitzgerald et al. reported that maximum voided volumes at subsequent days remained consistent with those from the first 24-h voiding diary [@pone.0069946-Fitzgerald1]. In our study, the baseline DVVmax between day 1, day 2, day 3 and their average were well correlated ([Table 5](#pone-0069946-t005){ref-type="table"}). In addition, the baseline and the change from baseline in day 1 DVVmax were all well correlated to those of DVVmaxavg (ρ = 0.88 and 0.74, respectively, all P\<0.001). Therefore, our results agree with these earlier reports, and it may also be appropriate to use 1-day bladder diary to estimate DVVmax.

From the ROC curve analysis ([Figure 7](#pone-0069946-g007){ref-type="fig"}), DVVmaxavg \<250 ml may be a good criterion to screen for bladder oversensitivity. Although DVVmaxavg had a higher ROC area, day 1 DVVmax \<250 ml showed similar sensitivity and specificity and therefore also appears to be a good clinical alternative parameter for screening.

Our study was limited in that the study population was entirely Taiwanese, and therefore our results might not be able to be generalised to other populations. Also, the retrospective nature of this study may have biased the results. However, we believe the large sample size should make our results reliable. Third, cases with different life style could influence their voiding behaviour, such as toilet time control because of working or other reasons, different medicine administration, et al., and thus might bias the correlation between bladder dairy and cystometric parameters. Finally, the 3-day bladder diary may be difficult for some patients to complete correctively, especially those that have a job, and this may also have biased our findings.

Conclusions {#s4a}
-----------

DVVmaxavg appears to be the bladder diary parameter best correlated with VSD. DVVmaxavg or day 1 DVVmax may be useful in screening for bladder oversensitivity and assessing efficacy of bladder storage disorder treatments.
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